The safety and tolerability of switching from a non-failing antiretroviral regimen to lopinavir.

Y Gilleece, S Mandalia, D Parmar, M Nelson

Journal: The Journal of infection 2003;46(3):204-5

PMID: 12643876

Full Text on Elsevier Science View on PubMed

Abstract

DOI: 10.1053/jinf.2002.1114

Link outs

Free resources

Medical:

https://medlineplus.gov/hivinwomen.html

Subscription / membership required

Full Text Sources:

https://linkinghub.elsevier.com/retrieve/pii/S0163...

MeSH Terms: Adult, CD4 Lymphocyte Count, Cholesterol, Female, HIV Infections, HIV-1, Humans, Lopinavir, Male, Middle Aged, Pyrimidinones, Triglycerides, Viral Load

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.